Evidence map›Paper›PMID 33744469›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2021

Bioinspired artificial exosomes based on lipid nanoparticles carrying let-7b-5p promote angiogenesis in vitro and in vivo.

Sezin Aday, Inbal Hazan-Halevy, Aranzazu Chamorro-Jorganes, Maryam Anwar, Meir Goldsmith, Nicholas Beazley-Long, Susmita Sahoo, Navneet Dogra, Walid Sweaad, Francesco Catapano and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Sezin AdayBristol Heart Institute, University of Bristol, Bristol BS2 8ED, UK; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Inbal Hazan-HalevyLaboratory of Precision NanoMedicine, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.
Aranzazu Chamorro-JorganesNational Heart and Lung Institute, Imperial College London, London W12 0NN, UK.
Maryam AnwarNational Heart and Lung Institute, Imperial College London, London W12 0NN, UK.
Meir GoldsmithLaboratory of Precision NanoMedicine, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.
Nicholas Beazley-LongBiodiscovery Institute, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Susmita SahooIcahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Navneet DograIcahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Walid SweaadNational Heart and Lung Institute, Imperial College London, London W12 0NN, UK.
Francesco CatapanoNational Heart and Lung Institute, Imperial College London, London W12 0NN, UK.
Sho Ozaki-TanNational Heart and Lung Institute, Imperial College London, London W12 0NN, UK.
Gianni D AngeliniBristol Heart Institute, University of Bristol, Bristol BS2 8ED, UK.
Paolo MadedduBristol Heart Institute, University of Bristol, Bristol BS2 8ED, UK.
Andrew V BenestBiodiscovery Institute, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Dan PeerLaboratory of Precision NanoMedicine, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel. Electronic address: peer@tauex.tau.ac.il.
Costanza EmanueliBristol Heart Institute, University of Bristol, Bristol BS2 8ED, UK; National Heart and Lung Institute, Imperial College London, London W12 0NN, UK. Electronic address: c.emanueli@imperial.ac.uk.
Imperial College London · GBTel Aviv University · ILUniversity of Bristol · GBIcahn School of Medicine at Mount Sinai · USUniversity of Nottingham · GBNIHR Bristol Cardiovascular Biomedical Research Unit · GB

Funding

British Heart Foundation CH/15/1/31199British Heart Foundation CH/1992027/7163British Heart Foundation PG/11/67/29067British Heart Foundation PG/18/31/33759British Heart Foundation RG/20/9/35101Department of Health
6 · The paper itself

Abstract

MicroRNAs (miRNAs) regulate gene expression by post-transcriptional inhibition of target genes. Proangiogenic small extracellular vesicles (sEVs; popularly identified with the name "exosomes") with a composite cargo of miRNAs are secreted by cultured stem cells and present in human biological fluids. Lipid nanoparticles (LNPs) represent an advanced platform for clinically approved delivery of RNA therapeutics. In this study, we aimed to (1) identify the miRNAs responsible for sEV-induced angiogenesis; (2) develop the prototype of bioinspired "artificial exosomes" (AEs) combining LNPs with a proangiogenic miRNA, and (3) validate the angiogenic potential of the bioinspired AEs. We previously reported that human sEVs from bone marrow (BM)-CD34

Indexed as

Neovascularization, PhysiologicAnimalsExosomesExtracellular VesiclesHumansHuman Umbilical Vein Endothelial CellsIn Vitro TechniquesLiposomesMiceMicroRNAsNanoparticlesPericardial FluidLipid NanoparticlesLiposomesMicroRNAsmirnlet7 microRNA, humanangiogenesisendothelial cellsextracellular vesicleslet-7b-5pmicroRNAsnanomedicine

Identifiers

PMID33744469
PMCPMC8261169
OpenAlexW3139369749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.